Novus Biologicals products are now on bio-techne.com

Recombinant Human Integrin alpha V beta 8 Protein, CF

Images

 
Recombinant human Integrin alpha V beta 8 (4135-AV) binds recombinant human LAP (246-LP) in a functional ELISA. The estimated Kd for this interaction is < 0.5 nM.

Product Details

Summary
Reactivity HuSpecies Glossary
Applications Binding Activity
Format
Carrier-Free

Order Details

Novus Biologicals is part of Bio-Techne

Shop this product on bio-techne.com

Recombinant Human Integrin alpha V beta 8 Protein, CF Summary

Details of Functionality
Measured by its binding ability in a functional ELISA. Immobilized Recombinant Human Integrin  alpha V beta 8 at 2 µg/mL can bind recombinant human Lap with an apparent Kd <0.5 nM.
Source
Chinese Hamster Ovary cell line, CHO-derived human Integrin alpha V beta 8 protein
Human Integrin alpha V
(Phe31-Val992)
Accession # NP_002201.1
His-Pro GGGSGGGS Acidic Tail
Human Integrin beta 8
(Glu43-Arg684)
Accession # P26012.1
His-Pro GGGSGGGS Basic Tail
N-terminus C-terminus
Accession #
N-terminal Sequence
Phe31 ( alpha V subunit) & Glu43 ( beta 8 subunit)
Protein/Peptide Type
Recombinant Proteins
Gene
ITGAV
Purity
>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Note
<0.01 EU per 1 μg of the protein by the LAL method.

Applications/Dilutions

Dilutions
  • Binding Activity
Theoretical MW
110.5 kDa ( alpha V subunit), 75.3 kDa ( beta 8 subunit).
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
SDS-PAGE
130-155 kDa and 85-100 kDa, reducing conditions
Publications
Read Publications using
4135-AV in the following applications:

Packaging, Storage & Formulations

Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 2 weeks, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
Buffer
Lyophilized from a 0.2 μm filtered solution in Tris, NaCl and MgCl2.
Purity
>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Reconstitution Instructions
Reconstitute at 100 μg/mL in sterile PBS.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Recombinant Human Integrin alpha V beta 8 Protein, CF

  • Integrin alpha V beta 8

Background

Integrin alpha V beta 8 is one of five alpha V integrins and the only known beta 8 integrin (1-3). The non-covalent heterodimer of 170 kDa alpha V and ~90 kDa beta 8 integrin type I transmembrane glycoprotein subunits is expressed in yolk sac, placenta, brain perivascular astrocytes, Schwann cells, renal glomerular mesangial cells and pulmonary epithelial cells (3-7). Unlike other alpha V integrins, alpha V beta 8 does not appear to assume different activation states, and the cytoplasmic tail does not connect to the cytoskeleton (3, 8). It binds ligands containing an RGD motif, including vitronectin, fibrin and the latency associated peptide (LAP) of the latent TGF-beta complex (7-12). High affinity binding of alpha V beta 8 to LAP allows proteolytic cleavage by MT1-MMP, which releases active TGF-beta . This mechanism differs from that of alpha V beta 6, the other alpha V integrin which can activate TGF-beta from latency through non-proteolytic mechanisms (13). Downstream effects of TGF-beta activation include control of cell growth and associated vascularization (10-13). Deletion of either alpha V or  beta 8 reveals that alpha V beta 8 is required for vascular morphogenesis in the embryonic brain and yolk sac (4, 14, 15). The 962 aa human alpha V extracellular domain (ECD) shares 92-95% aa sequence identity with mouse, rat and cow alpha V, while the 642 aa human beta 8 ECD shares 92%, 92%, 89%, 87% and 87% aa identity with cow, dog, rabbit, mouse and rat beta 8, respectively. The beta 8 ECD of beta 8 shows low (~35%) aa identity with other integrin beta subunits, and the cytoplasmic tail is unlike any other integrin. The alpha V ECD contains an N-terminal beta - propeller structure, followed by domains termed thigh, calf-1 and calf-2 (1). The beta 8 ECD contains a vWFA domain, which interacts with the alpha V beta -propeller to form a binding domain. Each subunit has a transmembrane sequence and a short cytoplasmic tail.

  1. Hynes, R. O. (2002) Cell 110:673.
  2. Suzuki, S. et al. (1987) J. Biol. Chem. 262:14080.
  3. Moyle, M. et al. (1991) J. Biol. Chem. 266:19650.
  4. Zhu, J. et al. (2002) Development 129:2891.
  5. Cambier, S. et al. (2000) Cancer Res. 60:7084.
  6. Lakhe-Reddy, S. et al. (2006) J. Biol. Chem. 281:19688.
  7. Chernousov, M. A. and D. J. Carey (2003) Exp. Cell Res. 291:514.
  8. Nishimura, S. L. et al. (1994) J. Biol. Chem. 269:28708.
  9. Milner, R. et al. (1999) J. Cell Sci. 112:4271.
  10. Cambier, S. et al. (2005) Am. J. Pathol. 166:1883.
  11. Fjellbirkeland, L. et al. (2003) Am. J. Pathol. 163:533.
  12. Araya, J. et al. (2006) Am. J. Pathol. 169:405.
  13. Mu, D. et al. (2002) J. Cell Biol. 157:493.
  14. Proctor, J. M. et al. (2005) J. Neurosci. 25:9940.
  15. McCarty, J. H. et al. (2005) Development 132:165.

Customers Who Viewed This Item Also Viewed...

2308-VN
Species: Hu
Applications: BA
NBP1-91258
Species: Bv, Ca, Eq, Fe, Hu, Mu, Po, Rt
Applications: ICC/IF, IHC, IHC-Fr, IHC-P, Simple Western, WB
DVE00
Species: Hu
Applications: ELISA
MAB4467
Species: Hu
Applications: IHC, KO, Simple Western, WB
AF808
Species: Mu
Applications: ELISA(Cap), ELISA(Det), ELISA(Sta), ICC, IHC, Neut, WB
AF1230
Species: Hu, Mu, Rt
Applications: IHC, KO, WB
NBP2-22203
Species: Hu, Pm, Mu, Rt
Applications: ELISA, Flow, ICC/IF, IHC, IHC-P, WB
NB100-524
Species: Hu, Mu
Applications: Flow-IC, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, IP, WB
7268-CT
Species: Hu
Applications: BA
NBP2-79843
Species: Hu
Applications: CyTOF-ready, ELISA, Flow, ICC/IF, IHC, IHC-P, PA, WB
AF887
Species: Hu, Mu, Rt
Applications: CyTOF-ready, IHC, ICFlow, Simple Western, WB
NBP2-67416
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-P, WB
AF796
Species: Mu
Applications: AdBlk, IHC, WB
MAB17781
Species: Hu
Applications: Block, CyTOF-ready, Flow, ICC, IP, KO
MMP200
Species: Ca, Hu, Mu, Po, Rt
Applications: ELISA
233-FB
Species: Hu
Applications: BA
AF2685
Species: Hu
Applications: IHC, Simple Western, WB
AF3628
Species: Hu, Mu, Rt
Applications: CyTOF-ready, Flow, ICC, IHC, Simple Western, WB
AF467
Species: Hu, Mu
Applications: CyTOF-ready, Flow, ICC, IHC, Simple Western, WB

Publications for Integrin alpha V beta 8 (4135-AV)(5)

We have publications tested in 2 confirmed species: Human, Mouse.

We have publications tested in 3 applications: Binding Assay, Bioassay, In Vivo.


Filter By Application
Binding Assay
(1)
Bioassay
(3)
In Vivo
(1)
All Applications
Filter By Species
Human
(3)
Mouse
(2)
All Species
Showing Publications 1 - 5 of 5.
Publications using 4135-AV Applications Species
M Bieri, R Hendrickx, M Bauer, B Yu, T Jetzer, B Dreier, PRE Mittl, J Sobek, A Plückthun, UF Greber, S Hemmi The RGD-binding integrins alphavbeta6 and alphavbeta8 are receptors for mouse adenovirus-1 and -3 infection PloS Pathogens, 2021-12-15;17(12):e1010083. 2021-12-15 [PMID: 34910784] (Bioassay, Human) Bioassay Human
E Dodagatta-, HY Ma, B Liang, J Li, DS Meyer, SY Chen, KH Sun, X Ren, B Zivak, MD Rosenblum, MB Headley, L Pinzas, NI Reed, JS Del Cid, BC Hann, S Yang, A Giddabasap, K Noorbehesh, B Yang, J Dal Porto, T Tsukui, K Niessen, A Atakilit, RJ Akhurst, D Sheppard Integrin &amp;alphav&amp;beta8 on T�cells suppresses anti-tumor immunity in multiple models and is a promising target for tumor immunotherapy Cell Reports, 2021-07-06;36(1):109309. 2021-07-06 [PMID: 34233193] (In Vivo, Mouse) In Vivo Mouse
Lynne A Murray The TGF-? inhibitory activity of antibody 37E1B5 depends on its H-CDR2 glycan MAbs, 2016-11-11;0(0):0. 2016-11-11 [PMID: 27834568] (Bioassay, Mouse) Bioassay Mouse
Barbariga , Marco, Curnis , Flavio, Spitaleri , Andrea, Andolfo , Annapaol, Zucchelli , Chiara, Lazzaro , Massimo, Magnani , Giuseppe, Musco , Giovanna, Corti , Angelo, Alessio , Massimo Oxidation-induced structural changes of ceruloplasmin foster NGR motif deamidation that promotes integrin binding and signaling. J Biol Chem, 2013-12-23;289(6):3736-48. 2013-12-23 [PMID: 24366863] (Bioassay, Human) Bioassay Human
Curnis F, Cattaneo A, Longhi R, Sacchi A, Gasparri AM, Pastorino F, Di Matteo P, Traversari C, Bachi A, Ponzoni M, Rizzardi GP, Corti A Critical role of flanking residues in NGR-to-isoDGR transition and CD13/integrin receptor switching. J. Biol. Chem., 2010-01-11;285(12):9114-23. 2010-01-11 [PMID: 20064928] (Binding Assay, Human) Binding Assay Human

Reviews for Integrin alpha V beta 8 (4135-AV) (0)

There are no reviews for Integrin alpha V beta 8 (4135-AV). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

FAQs for Integrin alpha V beta 8 (4135-AV) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Additional Integrin alpha V beta 8 Products

Blogs on Integrin alpha V beta 8

There are no specific blogs for Integrin alpha V beta 8, but you can read our latest blog posts.
Read our latest blog and use the new citation tool on bio-techne.com

Customers Who Bought This Also Bought

Contact Information

Product PDFs

Calculators

Concentration Calculator

The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.

=
÷

Review this Product

Be the first to review our Recombinant Human Integrin alpha V beta 8 Protein, CF and receive a gift card or discount.

Bioinformatics